文献速递消化道肿瘤与早癌消化内镜

梅内特里耶病患者的生存时间与胃癌风险

Survival Times of Patients With Menetrier's Disease and Risk of Gastric Cancer.
PubMed 文献 · Clin Gastroenterol Hepatol · 2020-03-14

该病例对照研究纳入1975年至2005年梅奥诊所诊断的76例梅内特里耶病患者,分析其临床特征、胃癌发生及生存情况。5年和10年生存率分别为72.7%和65.0%,显著低于对照组。结论认为该病与死亡率增加相关,建议进行内镜监测。

要点

  • 梅内特里耶病患者5年生存率72.7%,10年生存率65.0%,均显著低于对照组。
  • 建议对梅内特里耶病患者进行内镜监测随访。

核心结论

  • 梅内特里耶病与死亡率增加相关,患者应接受内镜监测随访。

研究设计与样本

  • 病例对照研究,纳入1975年至2005年梅奥诊所诊断的76例梅内特里耶病患者,对照组为因消化不良行胃活检的患者。
  • 诊断基于临床、内镜、影像学和组织学特征的综合判断。
  • 采用Kaplan-Meier法估计总体生存率。

主要发现

  • 梅内特里耶病患者呕吐、腹痛、餐后饱胀、体重减轻≥10磅的比例显著高于对照组。
  • 幽门螺杆菌感染与梅内特里耶病无关联(患者2.6% vs 对照4.0%,P=1.00)。

临床怎么用

  • 对梅内特里耶病患者应进行内镜监测随访以早期发现胃癌。
  • 关注患者体重减轻、呕吐、腹痛、餐后饱胀等症状。
  • 吸烟与梅内特里耶病相关,戒烟可能有获益。
  • 幽门螺杆菌感染与梅内特里耶病无显著关联。
  • 炎症性肠病与梅内特里耶病无显著关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Menetrier's disease is a rare acquired disorder associated with giant gastric folds along with protein-losing enteropathy, low stomach acid, or achlorhydria, and histologic features of massive foveolar hyperplasia. Little is known about the etiology, clinical features, or epidemiology of this disorder, including risk of gastric cancer. We investigated the outcomes and characteristics of patients with Menetrier's disease, including development of gastric cancer and survival times. METHODS: We performed a case-control study of all Menetrier's disease cases (n = 76; mean age, 56 ± 45 y; 59% male; mean body mass index, 24) diagnosed at Mayo Clinic, Rochester, MN, from January 1975 through 2005. Diagnosis of Menetrier's disease was based on a combination of clinical, endoscopic, radiologic, and histologic features. Patients with dyspepsia who underwent gastric biopsy analysis were included as controls. We obtained demographic, clinical history, laboratory, imaging, histopathology, and follow-up data from medical records. Clinical characteristics of Menetrier's disease were analyzed using descriptive statistics. The Kaplan-Meier method was used to estimate overall survival in cases. RESULTS: Clinical features found in a significantly higher proportion of patients with Menetrier's disease than controls included vomiting, abdominal pain, postprandial fullness, and weight loss of 10 lb or more. Smoking was associated with Menetrier's disease (P = .002 vs controls), but not alcohol use. Infection with Helicobacter pylori was not associated with Menetrier's disease (2.6% of patients vs 4.0% of controls; P = 1.00). There was no significant difference between patients with Menetrier's disease vs controls in proportions with inflammatory bowel disease. Gastric cancer developed in 8.9% of patients with Menetrier's disease by 10 years after the Menetrier's disease diagnosis vs 3.7% of controls over the same time period (P = .09). Of patients with Menetrier's disease, 72.7% and 65.0% survived for 5 and 10 years, respectively, compared with 100% of controls (P < .0001 for both time periods). CONCLUSIONS: In a case-control study of 76 patients with Menetrier's disease, we found this rare disorder to be associated with increased mortality. Patients with Menetrier's disease therefore should be followed up with surveillance endoscopy.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Almazar AE, Penfield JD, Saito YA, et al. Survival Times of Patients With Menetrier's Disease and Risk of Gastric Cancer. Clin Gastroenterol Hepatol. 2020. PMID: 32184187. doi:10.1016/j.cgh.2020.03.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。